The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes.

Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases.

Alvin Powers, M.D., professor of Medicine and Molecular Physiology and Biophysics, has been named to the American Diabetes Association Board of Directors.

Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone.

The statistics are jarring. More than 25.8 million children and adults in the United States — 8.3 percent of the population — have diabetes. And predictions are that one in three people will have the chronic disease by 2050.

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.